Clindamycin Injection (IV/IM) bulk supplier for pharma manufacturers

Clindamycin Injection (Iv/Im) 300 mg/2 mL, 600 mg/4 mL Suppliers & Bulk Manufacturers

Available Forms: Injection (IV/IM)

Available Strengths: 300 mg/2 mL, 600 mg/4 mL

Reference Brands: Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU)

Clindamycin IV and IM inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, leading to bacterial cell death. It effectively treats severe skin, respiratory, and intra-abdominal infections. Benefits include rapid, reliable action against anaerobic bacteria, good tissue penetration, and clinical utility in hospital settings.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Clindamycin IV/IM is approved in the EU and US for severe bacterial infections, including skin, respiratory, and intra-abdominal infections. In the EU, brands like Cleocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for clindamycin IV/IM, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.

Clindamycin Injection (Iv/Im) — third party manufacturing & bulk supply

Clindamycin Injection (Iv/Im) 300 mg/2 mL, 600 mg/4 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Clindamycin Injection (Iv/Im) is supplied as Injection (IV/IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Clindamycin Injection (Iv/Im) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Clindamycin Injection (Iv/Im) →

Back to Listing

Frequently Asked Questions

Clindamycin Injection is used to treat serious bacterial infections caused by susceptible bacteria, particularly anaerobic bacteria and certain gram-positive organisms. It is commonly prescribed for respiratory tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, septicemia, and gynecological infections. The injectable form is typically used in hospital settings when oral therapy is not suitable or when rapid therapeutic action is required.

Clindamycin Injection contains the active pharmaceutical ingredient clindamycin phosphate, which is the injectable form of the antibiotic clindamycin. It belongs to the lincosamide class of antibiotics and works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of bacteria.

Clindamycin Injection is marketed under several trade names worldwide including Cleocin Injection, Dalacin C Injection, and other generic clindamycin injectable brands depending on the manufacturer and region.

One of the well-known brands, Cleocin Injection, was originally developed and marketed by Pfizer. Today, clindamycin injection is manufactured globally by several pharmaceutical companies including Teva Pharmaceutical Industries, Sandoz, and Viatris along with other generic manufacturers.

The generic name of Clindamycin Injection is clindamycin phosphate.

Common brand names of Clindamycin Injection include Cleocin Injection and Dalacin C Injection.

Clindamycin Injection is manufactured in several countries including the United States, India, China, and multiple European countries by different pharmaceutical manufacturers supplying both branded and generic injectable formulations for global markets.